Neuropathological mechanisms of seizures in autism spectrum disorder

Richard E. Frye, Manuel F. Casanova, S. Hossein Fatemi, Timothy D. Folsom, Teri J. Reutiman, Gregory L. Brown, Stephen M. Edelson, John C. Slattery, James Adams

Research output: Contribution to journalShort survey

23 Citations (Scopus)

Abstract

This manuscript reviews biological abnormalities shared by autism spectrum disorder (ASD) and epilepsy. Two neuropathological findings are shared by ASD and epilepsy: Abnormalities in minicolumn architecture and γ-aminobutyric acid (GABA) neurotransmission. The peripheral neuropil, which is the region that contains the inhibition circuits of the minicolumns, has been found to be decreased in the post-mortem ASD brain. ASD and epilepsy are associated with inhibitory GABA neurotransmission abnormalities including reduced GABAA and GABAB subunit expression. These abnormalities can elevate the excitation-to-inhibition balance, resulting in hyperexcitablity of the cortex and, in turn, increase the risk of seizures. Medical abnormalities associated with both epilepsy and ASD are discussed. These include specific genetic syndromes, specific metabolic disorders including disorders of energy metabolism and GABA and glutamate neurotransmission, mineral and vitamin deficiencies, heavy metal exposures and immune dysfunction. Many of these medical abnormalities can result in an elevation of the excitatory-to-inhibitory balance. Fragile X is linked to dysfunction of the mGluR5 receptor and Fragile X, Angelman and Rett syndromes are linked to a reduction in GABAA receptor expression. Defects in energy metabolism can reduce GABA interneuron function. Both pyridoxine dependent seizures and succinic semialdehyde dehydrogenase deficiency cause GABA deficiencies while urea cycle defects and phenylketonuria cause abnormalities in glutamate neurotransmission. Mineral deficiencies can cause glutamate and GABA neurotransmission abnormalities and heavy metals can cause mitochondrial dysfunction which disrupts GABA metabolism. Thus, both ASD and epilepsy are associated with similar abnormalities that may alter the excitatory-to-inhibitory balance of the cortex. These parallels may explain the high prevalence of epilepsy in ASD and the elevated prevalence of ASD features in individuals with epilepsy.

Original languageEnglish (US)
Article number192
JournalFrontiers in Neuroscience
Volume10
Issue numberMAY
DOIs
StatePublished - 2016

Fingerprint

gamma-Aminobutyric Acid
Seizures
Epilepsy
Synaptic Transmission
Glutamic Acid
Heavy Metals
Energy Metabolism
Minerals
Angelman Syndrome
Rett Syndrome
Aminobutyrates
Avitaminosis
Fragile X Syndrome
Phenylketonurias
Neuropil
Autism Spectrum Disorder
Interneurons
GABA-A Receptors
Urea
Brain

Keywords

  • Autism spectrum disorder
  • Epilepsy
  • Excitatory-to-inhibitory cortical balance
  • Gamma-aminobutyric acid
  • Genetic syndrome
  • Metabolic disorders
  • Seizures

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Frye, R. E., Casanova, M. F., Fatemi, S. H., Folsom, T. D., Reutiman, T. J., Brown, G. L., ... Adams, J. (2016). Neuropathological mechanisms of seizures in autism spectrum disorder. Frontiers in Neuroscience, 10(MAY), [192]. https://doi.org/10.3389/fnins.2016.00192

Neuropathological mechanisms of seizures in autism spectrum disorder. / Frye, Richard E.; Casanova, Manuel F.; Fatemi, S. Hossein; Folsom, Timothy D.; Reutiman, Teri J.; Brown, Gregory L.; Edelson, Stephen M.; Slattery, John C.; Adams, James.

In: Frontiers in Neuroscience, Vol. 10, No. MAY, 192, 2016.

Research output: Contribution to journalShort survey

Frye, RE, Casanova, MF, Fatemi, SH, Folsom, TD, Reutiman, TJ, Brown, GL, Edelson, SM, Slattery, JC & Adams, J 2016, 'Neuropathological mechanisms of seizures in autism spectrum disorder', Frontiers in Neuroscience, vol. 10, no. MAY, 192. https://doi.org/10.3389/fnins.2016.00192
Frye RE, Casanova MF, Fatemi SH, Folsom TD, Reutiman TJ, Brown GL et al. Neuropathological mechanisms of seizures in autism spectrum disorder. Frontiers in Neuroscience. 2016;10(MAY). 192. https://doi.org/10.3389/fnins.2016.00192
Frye, Richard E. ; Casanova, Manuel F. ; Fatemi, S. Hossein ; Folsom, Timothy D. ; Reutiman, Teri J. ; Brown, Gregory L. ; Edelson, Stephen M. ; Slattery, John C. ; Adams, James. / Neuropathological mechanisms of seizures in autism spectrum disorder. In: Frontiers in Neuroscience. 2016 ; Vol. 10, No. MAY.
@article{016254628a054554b76b192ef3de7220,
title = "Neuropathological mechanisms of seizures in autism spectrum disorder",
abstract = "This manuscript reviews biological abnormalities shared by autism spectrum disorder (ASD) and epilepsy. Two neuropathological findings are shared by ASD and epilepsy: Abnormalities in minicolumn architecture and γ-aminobutyric acid (GABA) neurotransmission. The peripheral neuropil, which is the region that contains the inhibition circuits of the minicolumns, has been found to be decreased in the post-mortem ASD brain. ASD and epilepsy are associated with inhibitory GABA neurotransmission abnormalities including reduced GABAA and GABAB subunit expression. These abnormalities can elevate the excitation-to-inhibition balance, resulting in hyperexcitablity of the cortex and, in turn, increase the risk of seizures. Medical abnormalities associated with both epilepsy and ASD are discussed. These include specific genetic syndromes, specific metabolic disorders including disorders of energy metabolism and GABA and glutamate neurotransmission, mineral and vitamin deficiencies, heavy metal exposures and immune dysfunction. Many of these medical abnormalities can result in an elevation of the excitatory-to-inhibitory balance. Fragile X is linked to dysfunction of the mGluR5 receptor and Fragile X, Angelman and Rett syndromes are linked to a reduction in GABAA receptor expression. Defects in energy metabolism can reduce GABA interneuron function. Both pyridoxine dependent seizures and succinic semialdehyde dehydrogenase deficiency cause GABA deficiencies while urea cycle defects and phenylketonuria cause abnormalities in glutamate neurotransmission. Mineral deficiencies can cause glutamate and GABA neurotransmission abnormalities and heavy metals can cause mitochondrial dysfunction which disrupts GABA metabolism. Thus, both ASD and epilepsy are associated with similar abnormalities that may alter the excitatory-to-inhibitory balance of the cortex. These parallels may explain the high prevalence of epilepsy in ASD and the elevated prevalence of ASD features in individuals with epilepsy.",
keywords = "Autism spectrum disorder, Epilepsy, Excitatory-to-inhibitory cortical balance, Gamma-aminobutyric acid, Genetic syndrome, Metabolic disorders, Seizures",
author = "Frye, {Richard E.} and Casanova, {Manuel F.} and Fatemi, {S. Hossein} and Folsom, {Timothy D.} and Reutiman, {Teri J.} and Brown, {Gregory L.} and Edelson, {Stephen M.} and Slattery, {John C.} and James Adams",
year = "2016",
doi = "10.3389/fnins.2016.00192",
language = "English (US)",
volume = "10",
journal = "Frontiers in Neuroscience",
issn = "1662-4548",
publisher = "Frontiers Research Foundation",
number = "MAY",

}

TY - JOUR

T1 - Neuropathological mechanisms of seizures in autism spectrum disorder

AU - Frye, Richard E.

AU - Casanova, Manuel F.

AU - Fatemi, S. Hossein

AU - Folsom, Timothy D.

AU - Reutiman, Teri J.

AU - Brown, Gregory L.

AU - Edelson, Stephen M.

AU - Slattery, John C.

AU - Adams, James

PY - 2016

Y1 - 2016

N2 - This manuscript reviews biological abnormalities shared by autism spectrum disorder (ASD) and epilepsy. Two neuropathological findings are shared by ASD and epilepsy: Abnormalities in minicolumn architecture and γ-aminobutyric acid (GABA) neurotransmission. The peripheral neuropil, which is the region that contains the inhibition circuits of the minicolumns, has been found to be decreased in the post-mortem ASD brain. ASD and epilepsy are associated with inhibitory GABA neurotransmission abnormalities including reduced GABAA and GABAB subunit expression. These abnormalities can elevate the excitation-to-inhibition balance, resulting in hyperexcitablity of the cortex and, in turn, increase the risk of seizures. Medical abnormalities associated with both epilepsy and ASD are discussed. These include specific genetic syndromes, specific metabolic disorders including disorders of energy metabolism and GABA and glutamate neurotransmission, mineral and vitamin deficiencies, heavy metal exposures and immune dysfunction. Many of these medical abnormalities can result in an elevation of the excitatory-to-inhibitory balance. Fragile X is linked to dysfunction of the mGluR5 receptor and Fragile X, Angelman and Rett syndromes are linked to a reduction in GABAA receptor expression. Defects in energy metabolism can reduce GABA interneuron function. Both pyridoxine dependent seizures and succinic semialdehyde dehydrogenase deficiency cause GABA deficiencies while urea cycle defects and phenylketonuria cause abnormalities in glutamate neurotransmission. Mineral deficiencies can cause glutamate and GABA neurotransmission abnormalities and heavy metals can cause mitochondrial dysfunction which disrupts GABA metabolism. Thus, both ASD and epilepsy are associated with similar abnormalities that may alter the excitatory-to-inhibitory balance of the cortex. These parallels may explain the high prevalence of epilepsy in ASD and the elevated prevalence of ASD features in individuals with epilepsy.

AB - This manuscript reviews biological abnormalities shared by autism spectrum disorder (ASD) and epilepsy. Two neuropathological findings are shared by ASD and epilepsy: Abnormalities in minicolumn architecture and γ-aminobutyric acid (GABA) neurotransmission. The peripheral neuropil, which is the region that contains the inhibition circuits of the minicolumns, has been found to be decreased in the post-mortem ASD brain. ASD and epilepsy are associated with inhibitory GABA neurotransmission abnormalities including reduced GABAA and GABAB subunit expression. These abnormalities can elevate the excitation-to-inhibition balance, resulting in hyperexcitablity of the cortex and, in turn, increase the risk of seizures. Medical abnormalities associated with both epilepsy and ASD are discussed. These include specific genetic syndromes, specific metabolic disorders including disorders of energy metabolism and GABA and glutamate neurotransmission, mineral and vitamin deficiencies, heavy metal exposures and immune dysfunction. Many of these medical abnormalities can result in an elevation of the excitatory-to-inhibitory balance. Fragile X is linked to dysfunction of the mGluR5 receptor and Fragile X, Angelman and Rett syndromes are linked to a reduction in GABAA receptor expression. Defects in energy metabolism can reduce GABA interneuron function. Both pyridoxine dependent seizures and succinic semialdehyde dehydrogenase deficiency cause GABA deficiencies while urea cycle defects and phenylketonuria cause abnormalities in glutamate neurotransmission. Mineral deficiencies can cause glutamate and GABA neurotransmission abnormalities and heavy metals can cause mitochondrial dysfunction which disrupts GABA metabolism. Thus, both ASD and epilepsy are associated with similar abnormalities that may alter the excitatory-to-inhibitory balance of the cortex. These parallels may explain the high prevalence of epilepsy in ASD and the elevated prevalence of ASD features in individuals with epilepsy.

KW - Autism spectrum disorder

KW - Epilepsy

KW - Excitatory-to-inhibitory cortical balance

KW - Gamma-aminobutyric acid

KW - Genetic syndrome

KW - Metabolic disorders

KW - Seizures

UR - http://www.scopus.com/inward/record.url?scp=84973551308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973551308&partnerID=8YFLogxK

U2 - 10.3389/fnins.2016.00192

DO - 10.3389/fnins.2016.00192

M3 - Short survey

VL - 10

JO - Frontiers in Neuroscience

JF - Frontiers in Neuroscience

SN - 1662-4548

IS - MAY

M1 - 192

ER -